Cargando…
Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro
Respiratory syncytial virus (RSV) is a major pathogen that causes severe lower respiratory tract infection in infants, the elderly and the immunocompromised worldwide. At present no approved specific drugs or vaccines are available to treat this pathogen. Recently, several promising candidates targe...
Autores principales: | Gao, Yuzhen, Cao, Jingjing, Xing, Pan, Altmeyer, Ralf, Zhang, Youming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125180/ https://www.ncbi.nlm.nih.gov/pubmed/33946996 http://dx.doi.org/10.3390/molecules26092607 |
Ejemplares similares
-
In vitro trackable assembly of RNA-specific nucleocapsids of the respiratory syncytial virus
por: Gao, Yunrong, et al.
Publicado: (2020) -
Protection against Respiratory Syncytial Virus Infection by DNA Immunization
por: Li, Xiaomao, et al.
Publicado: (1998) -
Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus
por: de la Sota, Patricia G., et al.
Publicado: (2021) -
Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013) -
Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)